ds-5141b
Peptideexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2015 (NCT02667483)
Timeline
Indications
Studied for
Mechanism of action
- DystrophinSupplementation
DMD supplementation
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- ds-5141b
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04433234 | Phase 2 | Jul 1, 2020 | Daiichi Sankyo |
| NCT02667483 | Phase 1/Phase 2 (Phase 2) | Oct 1, 2015 | Daiichi Sankyo, Orphan Disease Treatment Institute Co., Ltd. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Daiichi Sankyo | For profit | 2 | 2 | 1 | 2015 |
| Orphan Disease Treatment Institute Co., Ltd. | Academic/Hospital | 1 | 0 | 1 | 2015 |
2 organizations
Page 1 / 1